CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
AlteredExpression
|
disease |
BEFREE |
Co-expressing wt and CMD-mutant ANK in cells showed that CMD-mutant ANK does not negatively affect wt ANK expression and localization, and vice versa.
|
30356088 |
2018 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
We performed dentofacial examination of patients with CMD and evaluated consequences of orthodontic movement in a mouse model carrying a CMD knock-in (KI) mutation (Phe377del) in the Ank gene.
|
24663682 |
2014 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
CMD can be inherited in an autosomal dominant (AD) trait or occur after de novo mutations in the pyrophosphate transporter ANKH.
|
23951358 |
2013 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
Mutations for autosomal dominant CMD have been identified in the ANK gene (ANKH).
|
24219578 |
2013 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
One of the most common form is the autosomal dominant craniometaphyseal dysplasia (CMD) which is associated with mutation in the ANKH gene.
|
21465646 |
2011 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
Here, we investigated the effects of CMD-mutant ANK on mineralization and bone mass at a cellular level.
|
21149338 |
2011 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
Biomarker
|
disease |
MGD |
We generated the first knockin (KI) mouse model for CMD expressing a human mutation (Phe377 deletion) in ANK.
|
19257826 |
2009 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
We generated the first knockin (KI) mouse model for CMD expressing a human mutation (Phe377 deletion) in ANK.
|
19257826 |
2009 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
ANKH, the human homolog of the mutated gene in the ank/ank mouse, has been implicated in familial autosomal-dominant chondrocalcinosis and autosomal-dominant craniometaphyseal dysplasia.
|
14558096 |
2003 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK.
|
11326338 |
2001 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
UNIPROT |
Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK.
|
11326338 |
2001 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
GeneticVariation
|
disease |
UNIPROT |
Heterozygous mutations in ANKH, the human ortholog of the mouse progressive ankylosis gene, result in craniometaphyseal dysplasia.
|
11326272 |
2001 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.
|
9915952 |
1999 |
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
CRANIOMETAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT
|
0.990 |
Biomarker
|
disease |
CTD_human |
|
|
|
Calcium pyrophosphate arthropathy
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Our results suggest that neither ANKH nor ENPP1 mutations are the cause of CC in these families, indicating that possibly other major genes are involved in the aethiopathogenesis of this condition in these families.
|
21811784 |
2012 |
Calcium pyrophosphate arthropathy
|
0.750 |
GermlineCausalMutation
|
disease |
ORPHANET |
Pathophysiology of articular chondrocalcinosis--role of ANKH.
|
21102543 |
2011 |
Calcium pyrophosphate arthropathy
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Mutations in ANK result in two distinct calcification disorders: craniometaphyseal dysplasia and familial calcium pyrophosphate dihydrate deposition disease.
|
16462526 |
2006 |
Calcium pyrophosphate arthropathy
|
0.750 |
Biomarker
|
disease |
BEFREE |
The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease.
|
15474385 |
2004 |
Calcium pyrophosphate arthropathy
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in the amino terminus of ANKH in two US families with calcium pyrophosphate dihydrate crystal deposition disease.
|
13130483 |
2003 |
Calcium pyrophosphate arthropathy
|
0.750 |
Biomarker
|
disease |
BEFREE |
A discussion of ANKH as the familial calcium pyrophosphate dihydrate deposition disease gene is presented.
|
12707589 |
2003 |
Calcium pyrophosphate arthropathy
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Mutations in ANKH cause chondrocalcinosis.
|
12297987 |
2002 |
Calcium pyrophosphate arthropathy
|
0.750 |
GeneticVariation
|
disease |
UNIPROT |
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
|
12297989 |
2002 |
Calcium pyrophosphate arthropathy
|
0.750 |
GeneticVariation
|
disease |
BEFREE |
Autosomal dominant familial calcium pyrophosphate dihydrate deposition disease is caused by mutation in the transmembrane protein ANKH.
|
12297989 |
2002 |
Calcium pyrophosphate arthropathy
|
0.750 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Refinement of the chromosome 5p locus for familial calcium pyrophosphate dihydrate deposition disease.
|
9915952 |
1999 |